COMMONWEALTH EQUITY SERVICES, LLC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 109 filers reported holding KALA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 3.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$2,000
-33.3%
10,1920.0%0.00%
Q2 2022$3,000
-80.0%
10,192
-10.5%
0.00%
Q1 2022$15,000
+15.4%
11,3920.0%0.00%
Q4 2021$13,000
-61.8%
11,392
-12.2%
0.00%
Q3 2021$34,000
-54.7%
12,980
-9.4%
0.00%
Q2 2021$75,000
-14.8%
14,321
+8.8%
0.00%
Q1 2021$88,000
-26.7%
13,166
-26.2%
0.00%
Q4 2020$120,000
+26.3%
17,841
+39.4%
0.00%
Q3 2020$95,000
-29.1%
12,7970.0%0.00%
-100.0%
Q2 2020$134,000
+34.0%
12,797
+12.3%
0.00%
Q1 2020$100,000
+138.1%
11,3970.0%0.00%
Q4 2019$42,000
+2.4%
11,397
+4.4%
0.00%
Q3 2019$41,000
-40.6%
10,9130.0%0.00%
Q2 2019$69,000
-23.3%
10,9130.0%0.00%
Q1 2019$90,000
+76.5%
10,913
+4.6%
0.00%
Q4 2018$51,000
-61.7%
10,437
-22.7%
0.00%
-100.0%
Q3 2018$133,000
-28.1%
13,5010.0%0.00%0.0%
Q2 2018$185,000
-13.1%
13,5010.0%0.00%0.0%
Q1 2018$213,000
-22.0%
13,501
-8.5%
0.00%0.0%
Q4 2017$273,00014,7510.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,333,333$5,073,000100.00%
CAXTON CORP 1,483,343$5,644,0006.36%
Polaris Venture Management Co. V, L.L.C. 1,197,032$4,555,0002.59%
RA Capital Management 4,537,478$17,265,0001.03%
Orbimed Advisors 3,447,840$13,119,0000.25%
Matisse Capital 46,500$177,0000.22%
PURA VIDA INVESTMENTS, LLC 332,831$1,266,0000.22%
Sofinnova Investments, Inc. 478,206$1,819,0000.16%
HARBOURVEST PARTNERS LLC 99,186$377,0000.16%
ALGERT GLOBAL LLC 47,195$180,0000.07%
View complete list of KALA PHARMACEUTICALS INC shareholders